Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free EDT Stock Alerts

Spectral Medical (EDT) Competitors

Spectral Medical logo
C$1.39 -0.03 (-2.11%)
As of 03:50 PM Eastern
Compare

EDT vs. AKU, GEN, LMD, LXG, and SQD

Should you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), and SQI Diagnostics (SQD). These companies are all part of the "diagnostics & research" industry.

How does Spectral Medical compare to Akumin?

Akumin (TSE:AKU) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Akumin's average media sentiment score of 0.00 equaled Spectral Medical'saverage media sentiment score.

Company Overall Sentiment
Akumin Neutral
Spectral Medical Neutral

Akumin has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Comparatively, Spectral Medical has a beta of 0.647419, suggesting that its share price is 35% less volatile than the S&P 500.

30.3% of Akumin shares are held by institutional investors. Comparatively, 0.0% of Spectral Medical shares are held by institutional investors. 33.0% of Akumin shares are held by company insiders. Comparatively, 18.2% of Spectral Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Spectral Medical has lower revenue, but higher earnings than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AkuminC$737.69M0.00-C$255.80M-C$3.80N/A
Spectral MedicalC$2.44M167.02-C$18.68M-C$0.16N/A

Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Akumin-34.67% -483.86% 0.47%
Spectral Medical N/A -973.97%-93.22%

Summary

Akumin beats Spectral Medical on 6 of the 10 factors compared between the two stocks.

How does Spectral Medical compare to GeneNews?

GeneNews (TSE:GEN) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

GeneNews has higher earnings, but lower revenue than Spectral Medical. Spectral Medical is trading at a lower price-to-earnings ratio than GeneNews, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeneNewsC$234.59K0.00-C$11.56M-C$0.07N/A
Spectral MedicalC$2.44M167.02-C$18.68M-C$0.16N/A

GeneNews' return on equity of 0.00% beat Spectral Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
GeneNewsN/A N/A N/A
Spectral Medical N/A -973.97%-93.22%

0.0% of Spectral Medical shares are held by institutional investors. 18.2% of Spectral Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, GeneNews' average media sentiment score of 0.00 equaled Spectral Medical'saverage media sentiment score.

Company Overall Sentiment
GeneNews Neutral
Spectral Medical Neutral

Summary

GeneNews beats Spectral Medical on 5 of the 8 factors compared between the two stocks.

How does Spectral Medical compare to LED Medical Diagnostics?

LED Medical Diagnostics (CVE:LMD) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

0.0% of Spectral Medical shares are held by institutional investors. 18.2% of Spectral Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

LED Medical Diagnostics' return on equity of 0.00% beat Spectral Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
LED Medical DiagnosticsN/A N/A N/A
Spectral Medical N/A -973.97%-93.22%

LED Medical Diagnostics has higher revenue and earnings than Spectral Medical. LED Medical Diagnostics is trading at a lower price-to-earnings ratio than Spectral Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LED Medical DiagnosticsC$14.96M1.04-C$1.51M-C$0.04N/A
Spectral MedicalC$2.44M167.02-C$18.68M-C$0.16N/A

In the previous week, LED Medical Diagnostics' average media sentiment score of 0.00 equaled Spectral Medical'saverage media sentiment score.

Company Overall Sentiment
LED Medical Diagnostics Neutral
Spectral Medical Neutral

Summary

LED Medical Diagnostics beats Spectral Medical on 5 of the 9 factors compared between the two stocks.

How does Spectral Medical compare to LexaGene?

LexaGene (CVE:LXG) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

0.1% of LexaGene shares are owned by institutional investors. Comparatively, 0.0% of Spectral Medical shares are owned by institutional investors. 17.9% of LexaGene shares are owned by company insiders. Comparatively, 18.2% of Spectral Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

LexaGene has a beta of 2.26, meaning that its stock price is 126% more volatile than the S&P 500. Comparatively, Spectral Medical has a beta of 0.647419, meaning that its stock price is 35% less volatile than the S&P 500.

LexaGene's return on equity of -339.54% beat Spectral Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
LexaGeneN/A -339.54% -120.21%
Spectral Medical N/A -973.97%-93.22%

LexaGene has higher earnings, but lower revenue than Spectral Medical. Spectral Medical is trading at a lower price-to-earnings ratio than LexaGene, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LexaGeneC$110.93K133.13-C$8.54M-C$0.08N/A
Spectral MedicalC$2.44M167.02-C$18.68M-C$0.16N/A

In the previous week, LexaGene's average media sentiment score of 0.00 equaled Spectral Medical'saverage media sentiment score.

Company Overall Sentiment
LexaGene Neutral
Spectral Medical Neutral

Summary

LexaGene beats Spectral Medical on 6 of the 10 factors compared between the two stocks.

How does Spectral Medical compare to SQI Diagnostics?

SQI Diagnostics (CVE:SQD) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

SQI Diagnostics' return on equity of 0.00% beat Spectral Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SQI DiagnosticsN/A N/A -74.70%
Spectral Medical N/A -973.97%-93.22%

In the previous week, SQI Diagnostics' average media sentiment score of 0.00 equaled Spectral Medical'saverage media sentiment score.

Company Overall Sentiment
SQI Diagnostics Neutral
Spectral Medical Neutral

SQI Diagnostics has a beta of -0.21, indicating that its stock price is 121% less volatile than the S&P 500. Comparatively, Spectral Medical has a beta of 0.647419, indicating that its stock price is 35% less volatile than the S&P 500.

Spectral Medical has lower revenue, but higher earnings than SQI Diagnostics. Spectral Medical is trading at a lower price-to-earnings ratio than SQI Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SQI DiagnosticsC$3.04M2.01-C$19.14M-C$0.05N/A
Spectral MedicalC$2.44M167.02-C$18.68M-C$0.16N/A

25.2% of SQI Diagnostics shares are owned by institutional investors. Comparatively, 0.0% of Spectral Medical shares are owned by institutional investors. 50.2% of SQI Diagnostics shares are owned by company insiders. Comparatively, 18.2% of Spectral Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

SQI Diagnostics beats Spectral Medical on 7 of the 10 factors compared between the two stocks.

Get Spectral Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDT vs. The Competition

Export
MetricSpectral MedicalDiagnostics & Research IndustryMedical SectorTSE Exchange
Market CapC$407.85MC$44.63MC$6.25BC$11.72B
Dividend Yield1.45%3.51%2.74%6.22%
P/E Ratio-8.690.9424.9123.83
Price / Sales167.02607.69504.5613.46
Price / Cash82.5011.4243.3082.69
Price / Book-17.383.589.674.48
Net Income-C$18.68MC$334.07BC$3.55BC$300.68M
7 Day Performance0.72%2.68%1.70%0.12%
1 Month Performance-2.11%5.18%5.62%2.88%
1 Year Performance67.47%15.68%34.42%57.78%

Spectral Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDT
Spectral Medical
N/AC$1.39
-2.1%		N/AN/AC$407.85MC$2.44MN/A29
AKU
Akumin
N/AN/AN/AN/AC$37.20MC$737.69MN/A1,527
GEN
GeneNews
N/AN/AN/AN/AC$25.49MC$234.59KN/A2,700
LMD
LED Medical Diagnostics
N/AC$0.40
+∞		N/AN/AC$15.51MC$14.96MN/A46
LXG
LexaGene
N/AC$0.11
-19.2%		N/AN/AC$14.77MC$110.93KN/A41

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:EDT) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel